Skip to main content

Table 1 Characteristics of the two study cohorts

From: Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients

Variable

Derivation cohort

(number = 154)

Validation cohort

(number = 102)

P

Demographics

   

Age (years), mean ± SD

65.8 ± 16.2

65.8 ±17.0

0.97

Female gender, % (number)

55.2% (85)

43.1% (44)

0.06

Race, % (number)

  

<0.01

White

89.6%(138)

48.0% (49)

 

African-American

6.5% (10)

13.7% (14)

 

Hispanic

0 0% (0)

15.7% (16)

 

Asian

3.9% (6)

12.7% (13)

 

Other

0% (0)

9.8% (10)

 

Primary locus for sepsis, % (number)

  

<0.01

Respiratory tract

45.5% (70)

39.2% (40)

 

Intra-abdominal

21.4% (33)

13.7% (14)

 

Skin

0 (0)

2.0% (2)

 

Urinary tract

16.9% (26)

3.9% (4)

 

Bacteremia without organ specified

13.0% (20)

13.7% (14)

 

Other infections including nervous system, prosthesis, heart, abscesses

3.3% (5)

27.5% (28)

 

Type of admission, % (number)

  

0.68

Medical

83.1% (128)

84.3% (86)

 

Surgical

17.6% (26)

15.7% (16)

 

Admission risk score, mean ± SD

   

APACHE IV

81.8 ± 25.9

NA

 

SAPS II

NA

45.3 ± 14.3

 

PCT concentrations (µg/L), mean ± SD

  

Admission

32.6 ± 40.6

27.4 ± 44.9

0.34

After 72 ± 12 hours in ICU

13.3 ± 21.8

16.1 ± 40.4

0.46

Length-of-stay, days, mean ± SD

   

ICU

7.7 ± 6.3

6.9 ± 5.1

0.04

Total hospital

15.9 ± 10.7

15.4 ±10.1

0.66

Mortality, % (number), 95% CI

   

ICU

29.2% (45) 22.0% to 36.4%]

17.6% (18) 10.1% to 25.2%

0.04

Total in-hospital

31.8% (49) 24.4% to 39.3%

29.4% (30) 20.4% to 38.5%)

0.68

  1. APACHE, Acute Physiology, Age and Chronic Health Evaluation; CI, confidence interval; ICU, intensive care unit; PCT, procalcitonin; SAPS, Simplified Acute Physiology Score